Utilization of triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary

Hye-Jeong Choi1, Yonghyuk Lee1, Susin Park2

  • 1College of Pharmacy, Pusan National University, Busandaehakro 63 Bungil 2, Geumjeong-Gu, Busan, 46241, Republic of Korea.

Insights

Triple antithrombotic therapy (TAT) use increased significantly for atrial fibrillation (AF) patients undergoing percutaneous coronary intervention (PCI) from 2011 to 2020. However, many patients still did not receive optimal antithrombotic treatment.

Area of Science:

  • Cardiology
  • Pharmacology
  • Health Services Research

Background:

  • Triple antithrombotic therapy (TAT), combining oral anticoagulants and dual antiplatelet therapy (DAPT), is crucial for preventing ischemic events in atrial fibrillation (AF) patients post-percutaneous coronary intervention (PCI).
  • Concerns regarding bleeding risk limit the widespread adoption of TAT.
  • This study investigates TAT utilization and its determinants in the era of non-vitamin K antagonist oral anticoagulants (NOACs) using real-world data.

Purpose of the Study:

  • To analyze the trends in utilization of triple antithrombotic therapy (TAT) among patients with atrial fibrillation (AF) undergoing percutaneous coronary intervention (PCI).
  • To identify demographic and clinical factors influencing the adoption of TAT in the NOACs era.
  • To assess the adequacy of antithrombotic therapy in this high-risk patient population.

Main Methods:

  • Analysis of the National Inpatient Sample data from 2011-2020.
  • Inclusion of patients with AF who underwent PCI with stent implantation and had increased stroke risk.
  • Investigation of demographic and clinical factors using chi-squared test, Student t-test, and multiple logistic regression.

Main Results:

  • TAT utilization increased from 30.3% in 2011 to 65.4% in 2020 (p < 0.001).
  • Positive factors for TAT use included congestive heart failure, prior stroke/TIA/thromboembolism, valvular heart disease, and the study year.
  • Negative factors included specific insurance types, medical institution type, and comorbidities like renal disease, liver disease, and prior hemorrhage history.

Conclusions:

  • TAT use in high-stroke risk AF patients undergoing PCI showed a steady increase between 2011 and 2020.
  • Despite the increase, 29.4% of patients still received only DAPT in 2020, indicating suboptimal antithrombotic management.
  • Further research and clinical practice adjustments are needed to ensure optimal antithrombotic therapy for AF patients post-PCI.
Abstract

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
15
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
17
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
19
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
20
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
809
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
21